South Korea
· Delayed Price · Currency is KRW Sam-A Pharm. Statistics
Total Valuation
Sam-A Pharm. has a market cap or net worth of KRW 129.09 billion. The enterprise value is 66.44 billion.
| Market Cap | 129.09B |
| Enterprise Value | 66.44B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sam-A Pharm. has 6.10 million shares outstanding. The number of shares has increased by 33.87% in one year.
| Shares Outstanding | 6.10M |
| Shares Change (YoY) | +33.87% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 68.45% |
| Owned by Institutions (%) | n/a |
| Float | 1.93M |
Valuation Ratios
The trailing PE ratio is 5.22.
| PE Ratio | 5.22 |
| Forward PE | n/a |
| PS Ratio | 1.26 |
| PB Ratio | 0.61 |
| P/FCF Ratio | 5.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.13, with an EV/FCF ratio of 2.74.
| EV / Earnings | 2.69 |
| EV / Sales | 0.65 |
| EV / EBITDA | 2.13 |
| EV / EBIT | 2.45 |
| EV / FCF | 2.74 |
Financial Position
The company has a current ratio of 4.76, with a Debt / Equity ratio of 5.59.
| Current Ratio | 4.76 |
| Quick Ratio | 4.16 |
| Debt / Equity | 5.59 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | 0.49 |
| Interest Coverage | 126.84 |
Financial Efficiency
Return on equity (ROE) is 12.22% and return on invested capital (ROIC) is 8.27%.
| Return on Equity (ROE) | 12.22% |
| Return on Assets (ROA) | 7.54% |
| Return on Capital (ROIC) | 8.27% |
| Revenue Per Employee | 341.83M |
| Profits Per Employee | 82.48M |
| Employee Count | 300 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.88% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +26.88% |
| 50-Day Moving Average | 27,317.00 |
| 200-Day Moving Average | 19,790.80 |
| Relative Strength Index (RSI) | 34.90 |
| Average Volume (20 Days) | 76,778 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sam-A Pharm. had revenue of KRW 102.55 billion and earned 24.74 billion in profits. Earnings per share was 4,054.18.
| Revenue | 102.55B |
| Gross Profit | 66.20B |
| Operating Income | 27.87B |
| Pretax Income | 32.93B |
| Net Income | 24.74B |
| EBITDA | 32.00B |
| EBIT | 27.87B |
| Earnings Per Share (EPS) | 4,054.18 |
Balance Sheet
The company has 74.51 billion in cash and 11.86 billion in debt, giving a net cash position of 62.65 billion or 10,264.52 per share.
| Cash & Cash Equivalents | 74.51B |
| Total Debt | 11.86B |
| Net Cash | 62.65B |
| Net Cash Per Share | 10,264.52 |
| Equity (Book Value) | 212.39B |
| Book Value Per Share | 34,799.62 |
| Working Capital | 92.27B |
Cash Flow
In the last 12 months, operating cash flow was 30.25 billion and capital expenditures -5.97 billion, giving a free cash flow of 24.28 billion.
| Operating Cash Flow | 30.25B |
| Capital Expenditures | -5.97B |
| Free Cash Flow | 24.28B |
| FCF Per Share | 3,978.58 |
Margins
Gross margin is 64.55%, with operating and profit margins of 27.18% and 24.13%.
| Gross Margin | 64.55% |
| Operating Margin | 27.18% |
| Pretax Margin | 32.11% |
| Profit Margin | 24.13% |
| EBITDA Margin | 31.20% |
| EBIT Margin | 27.18% |
| FCF Margin | 23.68% |
Dividends & Yields
This stock pays an annual dividend of 750.00, which amounts to a dividend yield of 3.58%.
| Dividend Per Share | 750.00 |
| Dividend Yield | 3.58% |
| Dividend Growth (YoY) | 87.50% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 18.50% |
| Buyback Yield | -33.87% |
| Shareholder Yield | -30.29% |
| Earnings Yield | 19.17% |
| FCF Yield | 18.81% |
Stock Splits
The last stock split was on December 29, 2008. It was a forward split with a ratio of 1.02005.
| Last Split Date | Dec 29, 2008 |
| Split Type | Forward |
| Split Ratio | 1.02005 |